USANA Health Sciences, Inc.
Balance Sheet
| Line Item | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $158.4M | $181.8M | $330.4M | $288.4M | $311.9M | $234.8M | $214.3M | $247.1M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | $102.6M | $69.7M | $61.5M | $67.1M | $90.2M | $68.9M | $81.9M | $62.9M |
| Total Current Assets | $288.4M | $279.2M | $417.7M | $384.4M | $425.3M | $329.3M | $392.3M | $340.2M |
| Property, Plant & Equipment | $94.4M | $94.6M | $99.8M | $97.8M | $100.4M | $95.2M | $92.0M | $102.8M |
| Goodwill | $138.0M | $144.2M | $17.1M | $17.4M | $17.4M | $16.6M | $16.8M | $17.4M |
| Intangible Assets (Excl. Goodwill) | $133.2M | $151.8M | $29.9M | $32.4M | $30.8M | $29.8M | $31.8M | $35.2M |
| Total Assets | $742.9M | $748.2M | $632.8M | $596.5M | $640.9M | $516.9M | $554.5M | $519.3M |
| Liabilities | ||||||||
| Accounts Payable | $17.3M | $12.0M | $10.1M | $11.0M | $18.2M | $12.5M | $9.9M | $11.8M |
| Total Current Liabilities | $128.6M | $139.6M | $118.8M | $143.8M | $168.1M | $136.1M | $148.7M | $141.2M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $156.6M | $161.9M | $135.6M | $162.1M | $199.2M | $165.2M | $163.3M | $156.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $465.7M | $478.9M | $445.2M | $391.6M | $382.8M | $306.1M | $329.5M | $288.1M |
| Total Stockholders' Equity | $533.1M | $532.1M | $497.2M | $434.5M | $441.7M | $351.7M | $391.1M | $363.2M |